Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.22 (
cdc2
)
8,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
hDlg, the human homologue of the Drosophila Discs-large (Dlg) tumor suppressor protein, is known to interact with the tumor suppressor protein APC and the human papillomavirus E6 transforming protein. In a two-hybrid screen, we identified a 322-aa serine/threonine kinase that binds to the PDZ2 domain of hDlg. The mRNA for this
PDZ-binding kinase
, or PBK, is most abundant in placenta and absent from adult brain tissue. The protein sequence of PBK has all the characteristic protein kinase subdomains and a C-terminal PDZ-binding T/SXV motif. In vitro, PBK binds specifically to PDZ2 of hDlg through its C-terminal T/SXV motif. PBK and hDlg are phosphorylated at mitosis in HeLa cells, and the mitotic phosphorylation of PBK is required for its kinase activity. In vitro,
cdc2
/cyclin B phosphorylates PBK. This evidence shows how PBK could link hDlg or other PDZ-containing proteins to signal transduction pathways regulating the cell cycle or cellular proliferation.
...
PMID:Characterization of PDZ-binding kinase, a mitotic kinase. 1077 57
A
MAPKK-like protein kinase
TOPK
expresses in a wide range of proliferating cells and tissues such as cancer cells and testis. However, details of this kinase are still uncovered. We investigated the intracellular distribution of
TOPK
and its association with
cdk1
/cyclin B and microtubules. In interphase cells,
TOPK
expresses in cytosol and nucleus without any significant association with microtubule networks. During mitosis,
TOPK
-Thr-9 was phosphorylated by
cdk1
/cyclin B and
TOPK
significantly associates with mitotic spindles. When
TOPK
expression was suppressed, formation of spindle midzone was thinned and dimmed and cytokinesis was disturbed. We propose that
TOPK
plays a role in the formation of spindle midzone and in cytokinesis.
...
PMID:Characterization of a MAPKK-like protein kinase TOPK. 1554 88
Among normal organs and tissues, the MAPKK-like mitotic protein kinase
TOPK
is expressed exclusively in the testis. We analyzed the expression and phosphorylation of
TOPK
to address the functional role of this kinase during spermatogenesis.
TOPK
protein is expressed mainly in the cytosol of spermatocytes and spermatids, but not in spermatids and spermatogonia in situ.
TOPK
-Thr-9, a
cdk1
/cyclin B target residue, was specifically phosphorylated during mitotic and meiotic phases, while
TOPK
-Thr-198, a key amino acid for the ATP pocket, was constantly phosphorylated irrespective of the cell cycle. These data indicate that spermatogenic germ cells with vital proliferation activity express
TOPK
. As
TOPK
-Thr-9 was phosphorylated during both mitosis and meiosis,
TOPK
was indicted to play a role in cytokinesis and/or chromosomal segregation but not in DNA replication.
...
PMID:Expression and phosphorylation of TOPK during spermatogenesis. 1631 8
A MAPKK-like mitotic kinase,
TOPK
, implies the formation of mitotic spindles and spindle midzone and accomplishing cytokinesis, however, its underlying mechanism remains unclear. A microtubule bundling protein, PRC1, plays a pivotal role in the formation of mitotic spindles and spindle midzone. Because of their functional resemblance, we attempted to clarify the links between these two molecules.
TOPK
supported mitotic advance via the
cdk1
/cyclin B1-dependent phosphorylation of PRC1.
TOPK
induced the phosphorylation of PRC1 at T481 in vivo, however,
TOPK
did not phosphorylate PRC1 in vitro.
TOPK
induced the phosphorylation of PRC1 at T481 only when the
cdk1
/cyclin B1 existed simultaneously in vitro. Both the enzymatic activity of
TOPK
and association competence of
TOPK
with PRC1 were mandatory for this phosphorylation.
TOPK
binds to
cdk1
/cyclin B1, microtubules and PRC1 via its unique region near the C terminus.
TOPK
co-localized closely with
cdk1
throughout the cell cycle in vivo. Collectively, these data indicate that
TOPK
, which makes a kinase-substrate complex with
cdk1
/cyclin B1 and PRC1 on microtubules during mitosis, enhances the
cdk1
/cyclin B1-dependent phosphorylation of PRC1 and thereby strongly promotes cytokinesis.
...
PMID:A mitotic kinase TOPK enhances Cdk1/cyclin B1-dependent phosphorylation of PRC1 and promotes cytokinesis. 1751 44
Acute myeloid leukemia (AML) is a disorder involving hematopoietic stem cells, characterized by blockage of hematopoietic cell differentiation and an increase in clonal neoplastic proliferation. AML is associated with poor patient outcome.
PBK
/
TOPK
is a protein kinase derived from
PDZ-binding kinase
(
PBK
)/T-lymphokine-activated killer (T-LAK) cell-originated protein kinase (
TOPK
). Previous studies have shown that
PBK
/
TOPK
is expressed in hematologic tumors. In the present study, we aimed to investigate the role of
PBK
/
TOPK
in promyelocyte proliferation and to clarify the molecular mechanism.
PBK
/
TOPK
knockdown (KD) significantly decreased cell proliferation and viability in the NB4 and HL-60 promyelocytes.
PBK
/
TOPK
KD resulted in G2/M cell cycle arrest that attributed to a decrease in
cdc2
and cyclin B expression. In addition,
PBK
/
TOPK
KD caused apoptosis, as evidenced by activation of the mitochondrial apoptotic pathway and an increase in TUNEL-positive cells.
PBK
/
TOPK
KD induced mitochondrial dysfunction and ROS generation, and inhibition of mitochondrial dysfunction and ROS production suppressed
PBK
/
TOPK
KD-induced cell cycle arrest and apoptosis. Moreover,
PBK
/
TOPK
KD decreased Nrf2 expression and ARE-binding activity. Overexpression of Nrf2 inhibited the
PBK
/
TOPK
KD-induced decrease in
cdc2
and cyclin B expression and cell cycle arrest, and blocked ROS production and apoptosis. Based on literature and our results, it was demonstrated that Nrf2 may be a crucial regulator that mediates
PBK
/
TOPK
-exerted promotion of cell proliferation.
PBK
/
TOPK
stabilizes Nrf2, strictly regulates the ROS level, promotes cell cycle progression and inhibits apoptosis, contributing to the proliferation of promyelocytes. Our results provide new insights into the molecular mechanism of
PBK
/
TOPK
-mediated promyelocyte proliferation and shed light on the pathogenesis of AML.
...
PMID:PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis. 2650 18